Log has written
THURSDAY, NOVEMBER 26, 2009
Don’t abuse patents: scientists
The public sector has a key role in drug R&D. Patenting minor changes to extend monopoly prices spells misuse
Reply to comment
I am a 63 year CML patient. The cost of my Gleevec is $3,000 per month. My insurance covers most of it. In two years I will have to move to Medicare and it will cost me approximately $4,000 per year for this drug. It is my understanding that to qualify for assistance you must have no insurance at all. This drug will very likely allow me to live a full life span . . . my father lived to the age of 101. What insurance will fund my Gleevec for 720,000 should I live for only 20 years more and assume the price does not increase? If the answer is "what the market will bear" and you are dealing with a fata disease such as this, I guess the sky is the limit.
Nancy
  • Please use English to post and reply to comments
  • Please do not use offensive language in the form of racial or ethnic slurs, abuse or personal insults
  • We welcome opinion and debate geared towards finding solutions
  • Please keep comments relevant to the topic
First Name*
Last Name*
Email*
Comments*
Maximum characters allowed-2000
Enter code*
Disclaimer
All the content posted in this category are made by the readers of livemint unless specified otherwise. Livemint is not responsible for the opinions of the readers and the content posted by the readers are not respresentative of the views and opinions of livemint.